BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 42 filers reported holding BRIDGEBIO PHARMA INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $52,268,761 | -5.2% | 65,594,000 | -2.5% | 1.64% | -7.7% |
| Q1 2024 | $55,137,279 | -3.8% | 67,294,000 | 0.0% | 1.78% | -15.6% |
| Q4 2023 | $57,327,759 | +13.6% | 67,294,000 | 0.0% | 2.11% | +32.0% |
| Q3 2023 | $50,470,500 | +30.9% | 67,294,000 | +8.0% | 1.60% | +26.6% |
| Q2 2023 | $38,552,328 | +40.8% | 62,294,000 | +47.3% | 1.26% | +39.5% |
| Q1 2023 | $27,379,090 | +69.5% | 42,294,000 | 0.0% | 0.90% | +66.9% |
| Q4 2022 | $16,151,021 | – | 42,294,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 65,594,000 | $52,268,761 | 1.64% |
| Weiss Asset Management LP | 46,865,000 | $37,836,980 | 1.43% |
| Context Capital Management, LLC | 48,339 | $38,519,077 | 1.38% |
| SILVERBACK ASSET MANAGEMENT LLC | 10,000,000 | $8,075,872 | 0.99% |
| MACKAY SHIELDS LLC | 22,799,000 | $18,167,447 | 0.55% |
| LINDEN ADVISORS LP | 82,235,000 | $65,742,177 | 0.55% |
| ARISTEIA CAPITAL, L.L.C. | 30,780,000 | $24,527,129 | 0.54% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,193,000 | $18,698,867 | 0.45% |
| AQR Arbitrage LLC | 18,125,000 | $14,442,957 | 0.37% |
| SONA ASSET MANAGEMENT (US) LLC | 11,500,000 | $9,272,220 | 0.29% |